A survey on the influence of CYBATHLON on the development and acceptance of advanced assistive technologies.

Advanced assistive technology CYBATHLON Exoskeleton Functional electrical stimulation Prosthesis User-centered design Wheelchair

Journal

Journal of neuroengineering and rehabilitation
ISSN: 1743-0003
Titre abrégé: J Neuroeng Rehabil
Pays: England
ID NLM: 101232233

Informations de publication

Date de publication:
02 04 2022
Historique:
received: 12 11 2021
accepted: 18 03 2022
entrez: 3 4 2022
pubmed: 4 4 2022
medline: 6 4 2022
Statut: epublish

Résumé

Advanced assistive technologies (AAT) aim to exploit the vast potential of technological developments made in the past decades to improve the quality of life of people with disabilities. Combining complex robotic technologies with the unique needs of people with disabilities requires a strong focus on user-centered design to ensure that the AAT appropriately addresses the daily life struggles of target users. The CYBATHLON aims to promote this mindset by empowering the AAT target users ("pilots") to compete on race tracks that represent approximations of daily life obstacles. The objective of this work was to investigate the AAT technology development, usability, and user involvement (i.e., application of user-centered design) in the context of the CYBATHLON. With an online survey targeting the pilots and technical leads of teams preparing for the CYBATHLON 2020 Global Edition, we investigated to what extent the pilots were involved in device development and how this influences the perceived usability of the showcased AAT. Furthermore, the effects of user-centered design variables on the individual race performances were analyzed. A total of 81 responses from 35 pilots and 46 technical leads were collected in the two weeks prior to the event. Of all teams partaking in the included disciplines of the CYBATHLON 2020 Global Edition, 81.8% (36 of 44) were included in the study. User-centered design appeared to be a prevalent practice among the teams, as 85.7% of all pilots reported a certain level of involvement. However, only 25.5% of the pilots reported daily life usage, despite QUEST usability scores of both respondent groups showing moderate to high satisfaction with the respected AAT across all investigated disciplines. An explorative linear mixed model indicated that daily life usage (p < 0.05) and prolonged user involvement (e.g., more than 2 years, p < 0.001) have a significant positive effect on the race performance at the competition. We conclude that the CYBATHLON positively fulfills its conceptual goals of promoting active participation and inclusion of people with disabilities in the design and evaluation of AAT, thereby stimulating the development of promising novel technological solutions. Also, our data could underline the value of the competition as a benchmark, highlighting remaining usability limitations or technology adoption hurdles.

Sections du résumé

BACKGROUND
Advanced assistive technologies (AAT) aim to exploit the vast potential of technological developments made in the past decades to improve the quality of life of people with disabilities. Combining complex robotic technologies with the unique needs of people with disabilities requires a strong focus on user-centered design to ensure that the AAT appropriately addresses the daily life struggles of target users. The CYBATHLON aims to promote this mindset by empowering the AAT target users ("pilots") to compete on race tracks that represent approximations of daily life obstacles. The objective of this work was to investigate the AAT technology development, usability, and user involvement (i.e., application of user-centered design) in the context of the CYBATHLON.
METHODS
With an online survey targeting the pilots and technical leads of teams preparing for the CYBATHLON 2020 Global Edition, we investigated to what extent the pilots were involved in device development and how this influences the perceived usability of the showcased AAT. Furthermore, the effects of user-centered design variables on the individual race performances were analyzed.
RESULTS
A total of 81 responses from 35 pilots and 46 technical leads were collected in the two weeks prior to the event. Of all teams partaking in the included disciplines of the CYBATHLON 2020 Global Edition, 81.8% (36 of 44) were included in the study. User-centered design appeared to be a prevalent practice among the teams, as 85.7% of all pilots reported a certain level of involvement. However, only 25.5% of the pilots reported daily life usage, despite QUEST usability scores of both respondent groups showing moderate to high satisfaction with the respected AAT across all investigated disciplines. An explorative linear mixed model indicated that daily life usage (p < 0.05) and prolonged user involvement (e.g., more than 2 years, p < 0.001) have a significant positive effect on the race performance at the competition.
CONCLUSIONS
We conclude that the CYBATHLON positively fulfills its conceptual goals of promoting active participation and inclusion of people with disabilities in the design and evaluation of AAT, thereby stimulating the development of promising novel technological solutions. Also, our data could underline the value of the competition as a benchmark, highlighting remaining usability limitations or technology adoption hurdles.

Identifiants

pubmed: 35366930
doi: 10.1186/s12984-022-01015-5
pii: 10.1186/s12984-022-01015-5
pmc: PMC8976279
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

38

Informations de copyright

© 2022. The Author(s).

Références

Disabil Rehabil Assist Technol. 2011;6(3):225-42
pubmed: 20929425
J Neuroeng Rehabil. 2018 Jan 03;15(1):1
pubmed: 29298708
JMIR Rehabil Assist Technol. 2018 Nov 29;5(2):e10510
pubmed: 30497993
Int J Technol Assess Health Care. 2009 Oct;25(4):514-21
pubmed: 19845981
Disabil Rehabil Assist Technol. 2020 Sep 29;:1-9
pubmed: 32988251
J Neuroeng Rehabil. 2017 Nov 14;14(1):115
pubmed: 29137639
IEEE Int Conf Rehabil Robot. 2019 Jun;2019:1159-1166
pubmed: 31374786
IEEE Int Conf Rehabil Robot. 2017 Jul;2017:1639-1645
pubmed: 28814055
J Neuroeng Rehabil. 2018 Mar 13;15(1):18
pubmed: 29534730
Front Neurosci. 2018 Jan 11;11:756
pubmed: 29375294
Assist Technol. 1993;5(1):36-45
pubmed: 10171664
J Neuroeng Rehabil. 2018 Jan 03;15(1):3
pubmed: 29298695
Hum Factors. 2020 May;62(3):351-364
pubmed: 31928418
Eur J Transl Myol. 2017 Dec 06;27(4):7087
pubmed: 29299221
Sci Robot. 2018 Apr 25;3(17):
pubmed: 33141744
J Neuroeng Rehabil. 2017 Nov 29;14(1):124
pubmed: 29187203
J Sport Health Sci. 2020 Oct 14;:
pubmed: 33068748
Artif Organs. 2018 Mar;42(3):336-341
pubmed: 29516578
J Healthc Eng. 2016;2016:
pubmed: 27196802
J Neuroeng Rehabil. 2017 Nov 09;14(1):112
pubmed: 29121967
Int J Technol Assess Health Care. 2017 Jan;33(2):160-167
pubmed: 28849760
J Neuroeng Rehabil. 2016 May 31;13(1):49
pubmed: 27246601
Disabil Rehabil Assist Technol. 2018 Oct;13(7):716-723
pubmed: 29334475
J Neuroeng Rehabil. 2021 Dec 9;18(1):170
pubmed: 34886902
Front Robot AI. 2020 Nov 13;7:561774
pubmed: 33501326

Auteurs

Jan T Meyer (JT)

Rehabilitation Engineering Laboratory, ETH Zürich, Zürich, Switzerland. jan.meyer@hest.ethz.ch.

Selina Weber (S)

Rehabilitation Engineering Laboratory, ETH Zürich, Zürich, Switzerland.

Lukas Jäger (L)

CYBATHLON, ETH Zürich, Zürich, Switzerland.

Roland Sigrist (R)

CYBATHLON, ETH Zürich, Zürich, Switzerland.

Roger Gassert (R)

Rehabilitation Engineering Laboratory, ETH Zürich, Zürich, Switzerland.
CYBATHLON, ETH Zürich, Zürich, Switzerland.
Future Health Technologies, Singapore-ETH Centre, Campus for Research Excellence And Technological Enterprise (CREATE), Singapore, Singapore.

Olivier Lambercy (O)

Rehabilitation Engineering Laboratory, ETH Zürich, Zürich, Switzerland.
Future Health Technologies, Singapore-ETH Centre, Campus for Research Excellence And Technological Enterprise (CREATE), Singapore, Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH